Shield Therapeutics PLC (STXS)

Currency in GBP
4.13
+0.58(+16.34%)
Real-time Data·
STXS Scorecard
Full Analysis
Analysts do not anticipate the company will be profitable this year
Unusual trading volume
Fair Value
Day's Range
3.804.67
52 wk Range
0.035.87
Key Statistics
Bid/Ask
4.10 / 4.30
Prev. Close
3.55
Open
4
Day's Range
3.8-4.67
52 wk Range
0.03-5.87
Volume
10.54M
Average Volume (3m)
1.15M
1-Year Change
121.87%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
STXS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
13.73
Upside
+232.52%
Members' Sentiments
Bearish
Bullish
ProTips
High return over the last year

Shield Therapeutics PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Shield Therapeutics PLC Company Profile

Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, the United Kingdom.

Compare STXS to Peers and Sector

Metrics to compare
STXS
Peers
Sector
Relationship
P/E Ratio
−1.8x−6.0x−0.5x
PEG Ratio
−0.080.030.00
Price/Book
−38.2x1.4x2.6x
Price / LTM Sales
1.6x2.4x3.2x
Upside (Analyst Target)
319.0%51.8%42.7%
Fair Value Upside
Unlock17.9%5.8%Unlock

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 13.73
(+232.52% Upside)

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
20.05M / --
EPS Revisions
Last 90 days

STXS Income Statement

People Also Watch

80.20
RNO
0.00%
4.287
ICAG
+0.40%
198.60
ABDN
+0.46%
157.00
COSG
+1.03%
65.60
RKH
+3.47%

FAQ

What Stock Exchange Does Shield Therapeutics Trade On?

Shield Therapeutics is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for Shield Therapeutics?

The stock symbol for Shield Therapeutics is "STXS."

What Is the Shield Therapeutics Market Cap?

As of today, Shield Therapeutics market cap is 43.75M.

What Is Shield Therapeutics's Earnings Per Share (TTM)?

The Shield Therapeutics EPS (TTM) is -0.03.

From a Technical Analysis Perspective, Is STXS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Shield Therapeutics Stock Split?

Shield Therapeutics has split 0 times.

How Many Employees Does Shield Therapeutics Have?

Shield Therapeutics has 63 employees.

What is the current trading status of Shield Therapeutics (STXS)?

As of 23 Jul 2025, Shield Therapeutics (STXS) is trading at a price of 4.13, with a previous close of 3.55. The stock has fluctuated within a day range of 3.80 to 4.67, while its 52-week range spans from 0.03 to 5.87.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.